Company: GNMSF
Filing Date: 2025-02-12
Form Type: 20-F
Source: 0001558370-25-000846
Chunk: 120

Company: GENMAB A/S
Filing Date: 2025-02-12
Form: 20-F
Item: Item 7M
Chunk 120
---
, the persons named in the table have sole voting and investment power with respect to all shares owned by that person. The percentage of shares beneficially owned is computed on the basis of 66,187,186 shares outstanding as of February 12, 2025. Shares for which a person has the right to subscribe within 60 days of February 12, 2025 are deemed outstanding for purposes of computing the percentage ownership of the person holding such rights, but are not deemed outstanding for purposes of computing the percentage ownership of any other person. We conducted our last beneficial ownership analysis as of June 30, 2024 and we estimated that approximately 44%, or 29.2 million (including shares in the form of ADSs), of our outstanding shares as of such date were beneficially held by U.S. residents.
B.   Related-Party Transactions
In the year ended December 31, 2024, there were no material related party transactions. The Company has employment agreements with, and has made equity compensation grants to, members of Executive Management in the ordinary course of business. The Company also has remuneration packages for members of the Board of Directors. See 

95

“Item 6.B—Compensation”, Note 5.1 and Note 5.2 to our Audited Financial Statements included in our Annual Report 2024 for details on related party transactions.
C.   Interests of Experts and Counsel
Not applicable.